Hypertrophic cardiomyopathy induces changes in the tryptophan-5-hydroxylase, serotonin transporter and serotonergic receptors expressions.

Introduction: Cardiomyocytes have a biochemical machinery with the capacity to synthesize, utilize and reuptake serotonin.

Objective: To determine whether hypertrophic cardiomyopathy (HCM) induces changes in the expression of tryptophan-5-hydroxylase (TPH) 1 and 2, serotonin transporter (SERT) and serotonergic receptors (SR).

Methods: Cross-sectional study of five tissue blocks from hearts with HCM and five controls.

Triptófano-5-hidroxilasa, transportador de serotonina y receptores serotoninérgicos en miocardiopatía dilatada.

Background: Cardiomyocytes synthesize, utilize and reuptake serotonin, which is involved in the paracrine and autocrine modulation of heart activity and in the pathophysiology of some cardiovascular diseases.

Objective: To determine the expression of tryptophan-5-hydroxylase (TPH) 1 and 2, serotonin transporter protein (SERT) and serotonergic receptors in hearts with dilated cardiomyopathy (DCM) compared to controls.

Method: A comparative study was performed in six tissue blocks of the left ventricular free wall (LVWL) and inter-ventricular septum from patients who died of DCM and six who died of no cardiovascular diseases (controls).

[Tumors of the heart. 16 years experience in Hospital de Cardiología, del Centro Médico Nacional Siglo XXI in Mexico City].

Introduction: We present incidence of primary cardiac tumors diagnosed from 1987 at the Hospital de Cardiología, Centro Médico Nacional Siglo XXI, in Mexico City.

Objective: We described primary cardiac tumors based on histopathologic diagnosis, frequency, localization, implantation, implantation site, and recurrence.

Material And Methods: A total of 51 patient files were selected retrospectively.

Wolff-Parkinson-White syndrome associated to scimitar syndrome. Percutaneous radiofrequency catheter ablation previous to surgical repair.

Scimitar syndrome and Wolff-Parkinson-White association has not been reported during the era of catheter ablation. We present our personal experience with percutaneous radiofrequency ablation, a technical challenge related with Scimitar's anatomical variants and follow-up after surgical repair of the latter.